Programme

CPHIA 2021 will host thousands of participants from around the world for three days of engaging keynote presentations, plenary sessions, participatory sessions and panel discussions.

Conference Programme


3:00 – 3:50PM EAT
Opening Ceremony

Featured speakers include:

  • H.E Félix Antoine Tshisekedi Tshilombo, President, Democratic Republic of Congo; Chairperson of the African Union
  • H.E. Paul Kagame, President, Rwanda; AU Champion for Domestic Health Financing
  • H.E. Moussa Faki Mahamat, Chairperson, Commission of the African Union
  • Dr. Matshidiso Moeti, Director, WHO Regional Office for Africa
  • Prof. Agnes Binagwaho, Co-Chair, CPHIA 2021; Vice Chancellor and Professor of Pediatrics, University of Global Health Equity
  • Prof. Senait Fisseha, Co-Chair, CPHIA 2021; Director of Global Programs, The Susan Thompson Buffett Foundation
  • Dr. John Nkengasong, Director, Africa Centers for Disease Control and Prevention (Africa CDC)


4:00 – 5:30PM EAT
Plenary Session 1: Epidemiology of SARS-COV-2, Virology, Prevention and Clinical Management

While the African continent was predicted to be particularly vulnerable to COVID-19, African populations appear to have thus far evaded widespread morbidity and mortality due to the virus. This track will assess how the pandemic has unfolded on the African continent, discuss possible biologic mechanisms that may have mitigated the impact of the disease, identify areas of particular need for future research in the African setting, and discuss the future of COVID-19 in Africa.

Speakers:

  • Dr. John Nkengasong, Director, Africa CDC
  • Prof. Penny Moore, South African Research Chair of Virus-Host Dynamics and Reader / Associate Professor at the University of the Witwatersrand and the National Institute for Communicable Diseases (NICD)
  • Prof. Salim Abdool Karim, Director, CAPRISA
  • Prof. Ibrahim Abubakar, Dean of Faculty of Population Health Sciences, Professor of Infectious Disease Epidemiology, University College London (UCL)
  • Dr. Trevor Crowell, The Henry M. Jackson Foundation for the Advancement of Military Medicine (Co-moderator) 
  • Dr. Magda Robalo Correia e Silva, High Commissioner for COVID-19 pandemic response, Guinea-Bissau (Co-moderator)

5:30 – 7:00PM EAT
Session 1 Abstract Presentations

Session 1

  • Dr. Murray Dryden, Medical Officer/Principal Investigator, National Institute for Communicable Diseases, South Africa: Long COVID in South Africa: Persistent symptoms in patients hospitalized with SARS-CoV-2
  • Mr. Mark Otiende, KEMRI-Wellcome Trust Research Programme, Kenya: All-cause and cause-specific mortality in Kilifi Health and Demographic Surveillance System, in Kenya in the period of the COVID-19 pandemic
  • Dr. Aida Sivro, Senior Scientist, Centre for the AIDS Programme of Research in South Africa, South Africa: COVID-19 clinical presentation and SARS-CoV-2 viral kinetics in people living with HIV
  • Ms. Carroll Tshabane, South African Field Epidemiology Training Programme, South Africa: Estimation of Shedding Time in Laboratory-confirmed COVID-19 Cases in South Africa, 2020
  • Ms. Sona Jabang, Medical Research Council (MRC) Unit, The Gambia: Temporal dynamics of SARS-COV-2 viral load and related antibodies in West African patients: the COVADIS cohort
  • Dr. Dawit Wolday, Mekelle University (Co-moderator)
  • Ms. Lolem Ngong, Amref Health Africa (Co-moderator)

Session 2

  • Dr. Kerrigan McCarthy, National Institute for Communicable Diseases, South Africa: Establishing a national SARS-CoV-2 surveillance network across South Africa to support wastewater-based genomic and epidemiological monitoring of the COVID pandemic, 2020-2021
  • Dr. Sophie Uyoga, Research Scientist, KEMRI-Wellcome Trust Research Programme, Kenya: Prevalence of anti-SARS-CoV-2 IgG antibodies among Kenyan blood donors between June and August 2021
  • Dr. Sulaiman Lakoh, Lecturer, University of Sierra Leone; Dr Mohamed Bailor Barrie, Executive Director, Partners in Health, Sierra Leone: SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey
  • Dr. Hajer Letaief, National Observatory of New and Emerging Diseases, Tunisia: First national household seroprevalence survey of SARS-CoV 2 antibodies in Tunisia, April 2021
  • Dr. Kristen Stafford, Associate Professor, Center for International Health, Education, and Biosecurity, Institute of Human Virology, University of Maryland School of Medicine, Nigeria: SARS-CoV-2 seroprevalence across six states of Nigeria, October 2020 and June 2021
  • Prof. Pauline Byakika-Kibwika, Makerere University/IDI (Co-moderator)
  • Dr. Sofonias Tessema, Africa CDC (Co-moderator)

Session 3

  • Dr. Abdou Padane, Pharmacist, biologist, PhD student, L’Institut de Recherche en Santé, de Surveillance Épidémiologique et de Formations, Senegal: Evolution of variants of concern of SARS-CoV-2 during three waves in Senegal.
  • Mr. Claujens Chastel Mfoutou Mapanguy, Biologiste, Fondation Congolaise pour la Recherche Médicale, Congo: Genomic surveillance of SARS-CoV-2 variants circulating in the Brazzaville, Republic of Congo, December 2020–July 2021
  • Dr. Nicholas Bbosa, Scientist, MRC/UVRI & LSHTM Uganda Research Unit, Uganda: Genomic surveillance of SARS-CoV-2 in Uganda shows rapid replacement of variants, 2021
  • Dr. George Githinji, Bioinformatician, KEMRI–Wellcome Trust Research Programme, Kenya: Genomic surveillance of SARS-CoV-2 in Kenya: March 2020-October 2021
  • Dr. Nnaemeka Ndodo, Chief Molecular Bioengineer, Nigeria Centre for Disease Control, Nigeria: Tracking SARS-CoV2 variants and strains: an overview of Nigeria Centre for Disease Control’s first 596 sequences, November 2021
  • Ms. Akhona Tshangela, Africa CDC (Co-moderator)
  • Prof. Peter Olupot Olupot, Mbale Regional Referral Hospital (Co-moderator)

Session 4

  • Dr. Guy Harling, Faculty, Africa Health Research Institute, South Africa: Covid-19 vaccination uptake in uMkhanyakude district South Africa, April-November 2021
  • Dr. Emna Mziou, Resident in preventive and community medicine, National Observatory of New and Emerging Diseases, Tunisia: Evaluation of vaccine effectiveness against COVID-19: a case-control study on a Tunisian national sample, August 2021
  • Dr. Petro Terblanche, Managing Director, Afrigen Biologics, South Africa: mRNA Vaccine Technology Transfer and Training Hub in South Africa: A partnership model for sustainable vaccine production.
  • Dr. Imen Aouinti, Associate Professor, Tunisian Pharmacovigilance Centre, Tunisia: AEFI collected during COVID-19 vaccine campaign in Tunisia
  • Dr. Emem Iwara, Senior Surveillance Lead, University of Maryland Baltimore-Nigeria Program: Reactogenicity following first dose of COVID-19 vaccine in Nigeria 2021
  • Prof. Catherine Orrell, Desmond Tutu HIV Foundation (Co-moderator)
  • Mr. Jean Marie Habarugira, Senior Project Officer, EDCTP (Co-moderator)


11:00 – 12:30PM EAT
Plenary Session 2: Vaccination in Africa: Research Capacity, Advocacy, Manufacturing and Distribution

As the world looks toward preparing for future health threats, African countries need to strengthen their vaccine manufacturing capacities by bolstering regulatory agencies, developing the necessary human resource potential and attracting financial and technical investment. This track will explore the current state of COVID-19 vaccine distribution in Africa and the way forward, as well as the future of vaccine manufacturing on the continent.

Confirmed speakers include:

  • Dr. Benido Impouma, Director of Universal Health Coverage, Communicable & Non-Communicable Diseases, WHO Regional Office for Africa
  • Prof. Ernest Aryeetey, Secretary-General of the African Research Universities Alliance and African Economic Research Consortium (AERC) Board Chair at the University of Ghana
  • Madam Winnie Byanyima, Executive Director, UNAIDS
  • Prof. Petro Terblanche, Managing Director, Afrigen Biologics
  • Prof. Daniel Bausch, FIND, the global alliance for diagnostics (Co-moderator)
  • Prof. Romain Murenzi, Executive Director, UNESCO-TWAS
  • (Co-moderator)
Plenary Session 3: COVID-19 and Equitable Health System Strengthening in Africa

African countries and continental public health institutions have had to develop innovative approaches to meet the challenges presented by the COVID-19 pandemic – from a rapid expansion of diagnostic capacity and genomics, to pooling resources between nations and across the public-private sector. This track will explore case studies that can inform innovative approaches to building strong health systems in Africa.

Confirmed speakers include:

  • Rt. Hon. Dr. Michel Sidibe, Special Envoy for the African Medicines Agency, African Union
  • Honorable Minister Lt Col Dr. Tharcisse Mpunga, Minister of State in Charge of Primary Healthcare, Ministry of Health, Rwanda
  • Prof. Tulio de Oliveira, Director, Centre for Epidemic Response & Innovation, Professor, Stellenbosch University
  • Dr. Michael Makanga, Executive Director, EDCTP (Co-moderator)
  • Prof. Francine Ntoumi, Chair and Executive Director of the Congolese Foundation for Medical Research, Republic of Congo(Co-moderator)

1:00 – 2:30PM EAT
Plenary Session 3 Parallel Sessions

Panel: COVID-19 and Technological Opportunities

  • Prof. Oyewale Tomori, COVID-19 Technical Advisory Group, WHO
  • Dr. Kate O’Brien, Director of the Department of Immunization, Vaccines and Biologicals, WHO
  • Dr. Benjamin Schreiber, Deputy Chief, Global Immunization Program, UNICEF
  • Dr Justice Nonvignon, Ag Head, Health Economic Unit, Africa CDC
  • Dr. Ebere Okereke, Senior Technical Adviser, Tony Blair Institute for Global Change (Co-moderator)
  • Dr. Mohammed Abdulaziz, Head of Division, Disease Control and Prevention, Ag Head of Division, Surveillance, Africa CDC (Co-moderator)

Debate: Innovations emerging from the COVID-19 pandemic response increase Africa’s chances of achieving Universal Health Coverage

  • Prof. Isaac F. Adewole, Former Minister for Health of Nigeria
  • Dr. Stellah Wairimu Bosire, Co-Executive Director, UHAI East Africa Sexual Health and Rights Initiative
  • Tolu Adeleke-Aire, CEO and Founder, Tolu the Midwife Healthcare Solutions and The Maternity Hub Nigeria
  • Ayodeji Oluwole Odutolu, Senior Health Specialist in the African Region, World Bank
  • Dr Ifeanyi Nsofor, Senior Atlantic Fellow for Health Equity at George Washington University (Moderator)

Panel: COVID GAP – Joint Convening to Accelerate Global COVID-19 Vaccinations

  • Dr. Richard Mihigo, Immunizations and Vaccines Development Program Coordinator, WHO AFRO
  • Dr. Ahmed Ogwell Ouma, Deputy Director, Africa CDC
  • Ms. Michelle Seidel, Team Lead, Immunization Supply Chain, UNICEF
  • Dr. Meseret Zelalem, Director for Reproductive, Maternal, Newborn, Child, Adolescent, Youth Health and Nutrition, Ministry of Health, Ethiopia
  • Dr. Krishna Udayakumar, Founding Director, Duke Global Health Innovation Center (Moderator)

3:00 – 4:30PM EAT
Plenary Session 4: The Case for a New Public Health Order for Africa

The proposed New Public Health Order is an urgent call for Africa to strengthen public health institutions, decentralize public health engagements for more efficient implementation, bolster capacity for local production of vaccines, therapeutics and diagnostics, while creating significant investments in the health workforce and leadership programs, and building respectful public-private partnerships. This track will focus on two tenets of the New Public Health Order: building the capacity of the Africa CDC and National Public Health Institutes, and investing in the public health workforce.

Confirmed speakers include:

  • Dr. Chikwe Ihekweazu, Assistant Director-General, Health Emergency Intelligence, WHO
  • Dr. Natalie Mayet,  Deputy Director, National Institute for Communicable Diseases, and Chairperson, IANPHI-Africa.
  • Dr. Vera Songwe, Executive Secretary, United Nations Economic Commission for Africa
  • Dr. Amadou A. Sall, CEO, Institut Pasteur de Dakar
  • Dr. Githinji Gitahi, Group Chief Executive Officer, Amref Health Africa (Co-moderator)
  • Prof. Eche Ezeanolue, HealthySunrise Foundation (Co-moderator)

5:00 – 6:30PM EAT
Session 4 Parallel Sessions

Panel: Establishing a National Public Health Institute: A conversation with Dr. Chikwe Ihekweazu

  • Dr. Chikwe Ihekweazu, Assistant Director-General, WHO Health Emergency Intelligence
  • Oluwafunmilola Dare, CEO, Centre for Health Sciences Training, Research and Development (Moderator)

Panel: Getting to the business of economic and social recovery: AU Commission on COVID-19

  • Dr. Ama Pokuaa Fenny, Senior Research Fellow, Institute of Statistical, Social and Economics Research (ISSER), University of Ghana
  • Dr. Maha El Rabbat, Professor of Public Health, Cairo University; Former Egyptian Minister of Health
  • Prof. Olive Shisana, Advisor on Social Policy, Office of the President, Republic of South Africa
  • Dr. Lwazi Manzi, Head of Secretariat, AU Commission on COVID-19 (Moderator)

Panel: Futureproofing Africa’s health system

  • Prof. Glenda Gray, President and CEO, South African Medical Research Council, South Africa
  • Olumide Okunola, Senior Health Specialist, World Bank Nigeria
  • Mah-Sere Keita, Director of Programs, African Society for Laboratory Medicine
  • Seth Akumani, Head of Exploration, UNDP, Ghana
  • Dr. Rispah Walumbe, Health Policy Advisor, Amref (Moderator)

7:00 – 7:45PM EAT
Special CPHIA Session: Developing, Producing and Delivering Oral Therapeutics for COVID-19
  • Dr. John Nkengasong, Director, Africa CDC
  • Dr. Trevor Mundel, President of Global Health, Bill & Melinda Gates Foundation
  • Dr. Julie Gerberding, Executive Vice-President and Chief Patient Officer, Merck
  • Dr. Salim S. Abdool Karim, Director, CAPRISA
  • Dr. Agnes Binagwaho, Co-Chair, CPHIA 2021; Vice Chancellor and Professor of Pediatrics, University of Global Health Equity (Moderator)


11:00 – 12:30PM EAT
Plenary Session 5: Assessing the Response to COVID-19 in Africa to Prepare for Future Health Threats

While African countries have responded relatively well to the pandemic, the continent has faced a variety of challenges, including in some instances weak leadership; restrictions in the global supply chain with insufficient test kits, personal protective equipment and vaccines; and misinformation. This track will examine the effectiveness of Africa’s response to the COVID-19 pandemic and highlight key successes, challenges and lessons learned to prepare for future health threats. It will also explore ways to prevent the severe unintended economic and social consequences that often follow health crises such as COVID-19.

Confirmed speakers include:

  • Prof. Tom Kariuki, Former Director of Programmes, African Academy of Science
  • Prof. Helen Rees, Founder and Executive Director, Reproductive Health and HIV Institute, University of Witwatersrand, South Africa
  • Dr. Michael Makanga, Executive Director, European & Developing Countries Clinical Trials Partnership
  • Prof. Benedict Oramah, President and Chairman of the Board of Directors, African Export-Import Bank
  • Prof. Moses Bockarie, European & Developing Countries Clinical Trial Partnership (EDCTP) (Co-moderator)
  • Kedest Tesfagiorgis, the Bill & Melinda Gates Foundation (Co-moderator)
Plenary Session 6: Digitisation, Modelling and Analytics to Support an Effective Public Health Response to the COVID-19 Pandemic

The COVID-19 pandemic has accelerated the advent of digital tools and technologies for public health messaging, epidemiologic surveillance, screening and diagnosis for rapid case identification, interruption of community transmission and clinical care delivery. This track will explore how digitisation, modelling and analytics can be fruitfully employed to sustain the public health goals of quality, accessibility, efficiency and equity in health care.

Confirmed speakers include: 

  • Dr. Yvonne Mburu, Founder and Executive Director, Nexakili
  • Dr. Edem Adzogenu, Co-Chair of the Initiative’s Executive Committee, AfroChampions
  • Honorable Minister Dr Lia Tadesse, Ministry of Health, Ethiopia
  • Ms. Abimbola Adebakin, CEO, Advantage Health Africa
  • Prof. Man Charurat, Center for International Health Education and  Biosecurity, and Institute of Human Virology (Co-moderator)
  • Mr. Jean Philbert Nsengimana, Africa CDC (Co-moderator)

1:00 – 2:30PM EAT
Session 5 Abstract Presentations

Session 1

  • Dr. Muhammad Alkasaby, Research Fellow, London School of Hygiene and Tropical Medicine / UK Health Security Agency, Egypt; Mohammed Abdulaziz, Head of Division, Africa CDC: Strengthening public mental health in Africa in response to COVID-19
  • Dr. Herilinda Temba, Community Health Workers Initiative Coordinator, Africa CDC, Ethiopia: The Unsung Heroes in the COVID-19 Response: Lessons Learnt from the Partnership for Accelerated COVID 19 Testing Initiative in Africa. August 2020 – October 2021
  • Dr. Patience Mwine, Fellow, Uganda National Institute of Public Health, Uganda: Readiness of Health Facilities to Manage COVID-19 in Uganda, June 2021
  • Ms. Ronel Sewpaul, Statistician/Research Manager, Human Sciences Research Council of South Africa, South Africa: COVID-19 Vaccination intentions and related factors in South Africa: results from a large-scale public survey
  • Dr. Hana Rohan, Assistant Professor in Social Sciences, London School of Hygiene and Tropical Medicine, Ethiopia: Establishing an Africa-wide rumour tracking system for COVID-19
  • Prof. Ehimario Igumbor, Senior Epidemiology Adviser to the Director General, Nigeria CDC (Co-moderator)
  • Prof. Moses Bockarie, Director, EDCTP (Co-moderator)

Session 2

  • Dr. Salako Abideen, Research Fellow, Nigerian Institute of Medical Research, Nigeria: Impact of SARS-CoV-2 Pandemic on Health Care of People Living with HIV at a Large Treatment Centre in Lagos, Nigeria
  • Dr. Mareme Diallo, Medical Research Council Unit The Gambia at LSHTM, Senegal: How have health systems in The Gambia, Senegal and Burkina Faso managed COVID-19 from May 2020 to September 2021?
  • Mrs. Christie Tiwoda, Juriste en Santé, Ministry of Public Health Cameroon, Cameroon: The contribution of legal determinants to strengthening health security in Africa
  • Ms. Alexandra Fehr, Research Fellow, London School of Hygiene and Tropical Medicine, Ethiopia: Public Health and Social Measures: support and adherence in 19 AU MS
  • Mrs. Joy Ebonwu, Provincial Epidemiology Team Manager, National Institute for Communicable Diseases, South Africa: New networks in improving mortality surveillance beyond COVID-19, 2021
  • Prof. Charles Wiysonge, Director of Cochrane South Africa, South African Medical Research Council (SAMRC) (Co-moderator)
  • Prof. Alain Tehindrazanarivelo, Professor, University of Antananarivo (Co-moderator)
Session 6 Abstract Presentations

Session 1

  • Dr. Agnes Kiragga, Infectious Diseases Institute, Makerere University, Uganda: Data Mining of community pharmacy records unearthed massive self-medication for treatment of COVID-19 in Uganda
  • Dr. Harry Moultrie, Senior Medical Epidemiologist, National Institute for Communicable Diseases, South Africa: How Modelling and Analytics Informed the South African Government’s COVID-19 Planning and Budgeting
  • Dr. Emma Waiyaiya, PharmAccess Foundation, Kenya: MomCare Adaptations During the COVID-19 Pandemic in Kenya, September 2020
  • Dr. Shem Sam, Regional Coordinator, Lake Region Economic Bloc, Kenya: OTOI-NARIMA Model for Forecasting Seasonality of Covid-19 Waves: Case of Kenya
  • Prof. Hedia Bellali, Associate Professor / Medical Faculty of Tunis, Tunis El Manar University, Tunisia: Modelling death trends to support Public Health decisions in Tunisia
  • Prof. Tobias Rinke de Wit, Director of Research, PharmAccess Foundation (Co-moderator)
  • Dr. Marisa Klopper, Stellenbosch University (Co-moderator)

Session 2

  • Mr. Mohammed Majam, Head: Medical Technologies, Ezintsha, Wits University, South Africa: Using a digital health solution to support Antigen RDT (AgRDT) testing for COVID-19 at taxi ranks in Johannesburg, South Africa
  • Mr. Isaac Coffie, Graduate Research Assistant, Carnegie Mellon University Africa, Ghana: A Data Visualization Approach to Mitigating the Impacts of the Global COVID-19 Pandemic
  • Ms. Corrie Mevis Omollo, Research Social Scientist, Kenya Medical Research Institute / Center for Global Health Research, Kenya: Feasibility and Acceptability of Public-Private Partnership Model for Combatting COVID-19 in Kisumu, Kenya
  • Mr. Kennedy Okongo, Director East Africa-Medical Credit Fund Africa, Kenya: COVID-19 Impact on the Performance of Healthcare Medium Size Enterprises in Kenya and the Role of Flexible Digital Cash Advances to Absorb Economic Shocks
  • Ms. Lise Kabarere, Graduate research assistant and student, Carnegie Mellon University Africa, Rwanda: COVID-19 Data-Driven SIR Models, October 2021
  • Ms. Shingai Machingaidze, Africa CDC (Co-moderator)
  • Ms. Chiamaka Ojiako, Global Health Advocacy Incubator (Co-moderator)

3:00 – 4:30PM EAT
Plenary Session 7: Agenda 2063: Whole-of-society – Private Sector, Community and Leadership, Approach in Combatting COVID-19 and Other Emerging Diseases

Effective partnerships and collaborations across all sectors will be critical to winning the fight against COVID-19. This track will focus on what can be done to create and harmonize more effective platforms for public-private dialogue to strengthen health systems; the innovations and investments that should be prioritized to better prepare for and respond to future pandemics and outbreaks; how leveraging private sector supply chain best practices can improve health supply chains in low- and middle-income countries; the role of local leadership in effective testing and diagnostics; and community engagement best practices.

Confirmed speakers include:

  • Mrs. Grace Ssali Kiwanuka, Executive Director, Uganda Healthcare Federation
  • Dr. Ernest Darkoh, Founding Partner, BroadReach Group
  • Dr. Joel Mubiligi, Executive Director, Partners in Health
  • Dr. Donald Kaberuka, COVID-19 Special Envoy, African Union
  • Dr. Monique Wasunna, Drugs for Neglected Diseases Initiative, Africa Regional Office (Co-moderator)
  • Dr. Amit N. Thakker, Africa Health Business (Co-moderator)

4:30 – 6:00PM EAT
Session 7 Parallel Sessions

Panel: Boosting the manufacturing of vaccines in Africa

  • Stavros Nicolaou, Senior Executive responsible for Stategic Trade Development, Aspen Pharmacare Group
  • Mwai Ngibuini, Group Head of Business Development and Communication, Dawa Life Sciences
  • Ayman Lahlou Cheikh, CEO, Cooper Pharma
  • Dr. Morena Makhoana, CEO, Biovac
  • Dr. Krishna Udayakumar, Founding Director, Duke Global Health Innovation Center (Moderator)

Panel: Strategic community engagements to strengthen health systems in Africa

  • Tian Johnson, Founder, The African Alliance for HIV Prevention
  • Philana Mugenyi, Government Affairs Manager for Sub-Saharan Africa, Terumo BCT
  • Bright Simons, Founder and President, mPedigree
  • Dr. John Amuasi, Founder and Lead, African Research Network for Neglected Tropical Diseases (Moderator)

Debate: Harmonizing regulations to drive investments in vaccine in Africa

  • Dr. David Mukanga, Senior Program Officer Regulatory Affairs, Africa Systems, Bill & Melinda Gates Foundation
  • Dr. Thomas Nyirenda, Strategic Partnerships & Capacity Development Manager, EDCTP
  • Mrs. Delese Mimi-Darko, CEO, Ghana Food and Drugs Authority
  • Dr. Krishna Udayakumar, Founding Director, Duke Global Health Innovation Center (Moderator)

6:00 – 7:00PM EAT
Closing Ceremony
  • Dr. John Nkengasong, Director, Africa CDC
  • Dr. Tedros Adhanom Ghebreyesus, Director General, World Health Organization (WHO)
  • Dr. Olive Shisana, Special Policy Advisor to the President of South Africa
  • Dr. Daniel Ngamije, Minister of Health, Rwanda

Note: event timings listed below are not exact. For more information on these events, including specific times, and to register, please see here.

Day 0 – 13 December 2021
All day
Virtual Poster Hall open to all registered participants
8:00AM – 1:00PM EAT

Johnson & Johnson: COVID-19 vaccine work in Africa & implementation partnership with the AU

Chatham House: A Practical Perspective on Decolonizing Global Health

University of Southern California: Findings from the Mental Health and Wellness (MEHEWE) Study

2:00 – 7:00PM EAT

University of Toronto and Moi University:
Networks and partnership in LMIC: building reciprocal global health partnerships

Africa CDC: Africa CDC National Public Health Institutes

Africa CDC: African Women leaders in public health through history

Bohemian Smartlytics Limited: Leveraging technology to transform HIV care and management – SmartHIV Solution

COVID GAP: Joint Convening to Accelerate Global Covid-19 Vaccinations (invitation only)


Day 1 – 14 December 2021
8:00AM – 2:00PM EAT

Bill & Melinda Gates Foundation, Dalberg, Pandemic Action Network and Resolve to Save Lives: Prepared to Respond: COVID-19 Lessons for the Next Health Emergency (P2RF)

Amref: The State of UHC in Africa Report: Reflections on our progress and recommendations moving forward

Global Health Network: Connecting Excellence in Data Science across Africa

7:00 – 8:30PM EAT

CCA/HSRI:
Practical Private Sector Lessons for Strengthening Health Systems in Africa

ICRC:
Innovative Approaches and Partnerships to Address Current and Future Health Threats in Africa: A humanitarian perspective

African Alliance:
No community left behind! Charting a truly African, inclusive and accountable response to COVID-19

AfroChampions: Making Travel Bans History with African Innovation


Day 2 – 15 December 2021
8:00 – 10:30AM EAT

AHF: Africa Leadership on a new Global Public Health Convention

AfroPHC: Role of youth in Primary Healthcare (PHC) strengthening during the COVID-19 pandemic

PIH: Respond, Recover, Reimagine​: Building equitable, resilient health systems in the context of COVID-19​ on the African continent​

2:00 –4:00PM EAT

High Commission for COVID-19 of Guinea-Bissau/CPLP: Ministerial Side Event – Management of COVID-19 and Lessons


Day 3 – 16 December 2021
8:00 – 10:30AM EAT

CEPI: Vaccine Research, Development and Manufacturing in Africa: lessons learnt from COVID-19

Equilibre International RDC: Une mi- enquête socio-anthropologique à l’appui de la communication sur le Covid-19 en Afrique Centrale

MMV: Strengthening innovation capacity for public health security in Africa during and beyond COVID-19 – lessons learning from local manufacturing of antimalarials

Institut de Recherche pour le Développement (IRD) / ANRS Cameroun: Between vaccine equity and social perceptions of COVID-19 in Central and West Africa

7:00 – 8:30PM EAT

MSF: Getting noma out of the neglect – Screening and talk

PSRT: The Private Sector Roundtable (PSRT) on Global Health Security: The Private Sector’s Evolving Role in Health Emergencies

University of Maryland: Covid-19 Vaccination Access and Monitoring: Lessons Learned from Kenya and Nigeria

J&J: Ebola Virus Disease Prevention and Control Through Vaccination in Africa: Where We Are and Where We Are Going


Day 4 – 17 December 2021
8:00AM – 1:00PM EAT

IOM: Resetting the unfinished agenda on the health of migrants for equitable Health system: focus on Preparedness and response

University of Botswana: Evidence of genetic risk for HIV infection in Sub-Saharan Africa

MSF: A global pandemic: the need for localized response

FIND: Diagnostic action planning for SARS-CoV-2 variant detection and response

Africa-Europe Foundation: Addressing health workforces’ challenges in a changing health landscape

Ziccum: Thermostable dry powder vaccines-Transforming vaccine access and delivery in Africa

2:00 – 7:00PM EAT

Doctors Insight: Digital Health: Leveraging on Technologies to Improve Healthcare in Africa

AFREHealth: The AFREhealth Response to the COVID-19 pandemic in Africa

Community Health Impact Coalition: Implementation Support Guide: Development of a National Georeferenced Community Health Worker Master List Hosted in a Registry

Helmsley: Hidden Suffering: Prioritizing Chronic Care in the COVID Era

Download the detailed agenda document here.
For additional information on plenary speakers, see here.
English